Patents by Inventor Christopher D. Winslow

Christopher D. Winslow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8222039
    Abstract: A process for purification of water soluble polymers is provided. A polymer of interest can be separated from a mixture of polymers, provided the polymer of interest differs from other polymers in the mixture in the number of reactive terminal groups. The process involves derivatizing polymers at the reactive terminal groups with a derivatizing molecule, bearing either (i) two or three cationic or anionic ionizable groups, and a group capable of covalent bonding to the reactive terminal groups or (ii) three or four ionizable groups, at least one of which is capable of covalent bonding to the reactive terminal groups; followed by ion exchange. The process allows removal of PEG from MPEG, and can be used for polymers having an average size greater than 9,000 Da Derivatization may be reversible in order to allow re-use of recovered contaminant polymers.
    Type: Grant
    Filed: February 22, 2007
    Date of Patent: July 17, 2012
    Assignee: Biovectra Inc.
    Inventors: James F. Monthony, Li Yang, Kurt E. Kershaw, Christopher D. Winslow, John G. Riley
  • Publication number: 20100323452
    Abstract: A process for purification of water soluble polymers is provided. A polymer of interest can be separated from a mixture of polymers, provided the polymer of interest differs from other polymers in the mixture in the number of reactive terminal groups. The process involves derivatizing polymers at the reactive terminal groups with a derivatizing molecule, bearing either (i) two or three cationic or anionic ionizable groups, and a group capable of covalent bonding to the reactive terminal groups or (ii) three or four ionizable groups, at least one of which is capable of covalent bonding to the reactive terminal groups; followed by ion exchange. The process allows removal of PEG from MPEG, and can be used for polymers having an average size greater than 9,000 Da Derivatization may be reversible in order to allow re-use of recovered contaminant polymers.
    Type: Application
    Filed: February 22, 2007
    Publication date: December 23, 2010
    Applicant: BIOVECTRA INC.
    Inventors: James F. Monthony, LI Yang, Kurt E. Kershaw, Christopher D. Winslow, John G. Riley
  • Patent number: 6972331
    Abstract: 4-Oxo-4,5-dihydro-3H-pyrrolo[3,2-d] pyrimidine-7-carboxylic acid methyl ester and process for preparing are provided. The process for producing the 4-oxo-4,5-dihydro-3H-pyrrole[3,2-d]pyrimidine-7-carboxylic acid methyl ester comprises condensing 3-amino-1H-pyrrole-2,4-dicarboxylic acid dimethyl ester with formamidine acetate. The 4-oxo-4,5-dihydro-3H-pyrrole[3,2-d]pyrimidine- 7-carboxylic acid methyl ester is useful as a precusor for providing 9-deaza-hypoxanthine, a key intermediate for producing certain PNP inhibitors.
    Type: Grant
    Filed: April 23, 2003
    Date of Patent: December 6, 2005
    Assignee: BioCryst Pharmaceuticals, Inc.
    Inventors: Christopher D. Winslow, Philip E. Morris, Jr.
  • Publication number: 20040214840
    Abstract: 4-Oxo-4,5-dihydro-3H-pyrrolo[3,2-d] pyrimidine-7-carboxylic acid methyl ester and process for preparing are provided. The 4-oxo-4,5-dihydro-3H-pyrrole[3,2-d] pyrimidine-7-carboxylic acid methyl ester is useful as a precursor for providing 9-deaza-hypoxanthine, a key intermediate for producing certain PNP inhibitors.
    Type: Application
    Filed: April 23, 2003
    Publication date: October 28, 2004
    Applicant: BIOCRYST PHARMACEUTICALS, INC.
    Inventors: Christopher D. Winslow, Philip E. Morris